Literature DB >> 26856912

Rapidly Progressing Chagas Cardiomyopathy.

John Hollowed1, Matthew McCullough2, Daniel Sanchez2, Mahmoud Traina2, Salvador Hernandez2, Efrain Murillo2.   

Abstract

Chagas disease, caused by the parasite Trypanosoma cruzi, can cause a potentially life-threatening cardiomyopathy in approximately 10-40% of afflicted individuals. The decline in cardiac function characteristically progresses over the course of many years. We report a case of Chagas disease in which the patient experienced an atypical rapid deterioration to severe cardiomyopathy over the course of 16 months. This case argues the need for increased routine surveillance for patients with confirmed T. cruzi infection, who are determined to be at high-risk for worsening cardiomyopathy. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 26856912      PMCID: PMC4824235          DOI: 10.4269/ajtmh.15-0616

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

Review 1.  Chagas cardiomyopathy--where do we stand after a hundred years?

Authors:  Andréia Biolo; Antonio L Ribeiro; Nadine Clausell
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

Review 2.  [Indeterminate form of Chagas disease: considerations about diagnosis and prognosis].

Authors:  A L Ribeiro; M O Rocha
Journal:  Rev Soc Bras Med Trop       Date:  1998 May-Jun       Impact factor: 1.581

Review 3.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

Review 4.  Clinical aspects of the Chagas' heart disease.

Authors:  Gopikrishna Punukollu; Ramesh M Gowda; Ijaz A Khan; Victor S Navarro; Balendu C Vasavada
Journal:  Int J Cardiol       Date:  2007-02-14       Impact factor: 4.164

Review 5.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

6.  Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.

Authors:  Rodolfo Viotti; Carlos Vigliano; Bruno Lococo; Graciela Bertocchi; Marcos Petti; María Gabriela Alvarez; Miriam Postan; Alejandro Armenti
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

Review 7.  Predictors of mortality in chronic Chagas disease: a systematic review of observational studies.

Authors:  Anis Rassi; Anis Rassi; Sérgio G Rassi
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

Review 8.  Clinical and epidemiological aspects of Chagas disease.

Authors:  A Prata
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

9.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 10.  Pathophysiology of the heart in Chagas' disease: current status and new developments.

Authors:  Maria de Lourdes Higuchi; Luiz Alberto Benvenuti; Marcia Martins Reis; Martin Metzger
Journal:  Cardiovasc Res       Date:  2003-10-15       Impact factor: 10.787

View more
  2 in total

1.  Fatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador.

Authors:  Manuel Calvopina; Gabriela Segovia; William Cevallos; Yosselin Vicuña; Jaime A Costales; Angel Guevara
Journal:  BMC Infect Dis       Date:  2020-02-14       Impact factor: 3.090

2.  Rapid Progressive Chagasic Myocarditis: A Multifactorial Condition.

Authors:  Andrés F Henao-Martínez
Journal:  Am J Trop Med Hyg       Date:  2016-07-06       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.